Tuberculosis and other opportunistic infections in tofacitinib-treated patients with rheumatoid arthritis

Date
2016
Author
GOMEZ-REINO, J. J.
Gül, Ahmet
CARDIEL, M. H.
TANAKA, Y.
KWOK, K.
LUKIC, T.
MORTENSEN, E.
PONCE DE LEON, D.
RIESE, R.
VALDEZ, H.
WINTHROP, K. L.
PARK, S-H
Metadata
Show full item record
Abstract
Objectives To evaluate the risk of opportunistic infections (OIs) in patients with rheumatoid arthritis (RA) treated with tofacitinib.
URI
http://hdl.handle.net/20.500.12627/38190
https://doi.org/10.1136/annrheumdis-2015-207319
Collections